Toronto, Canada

Richard A Isbrucker


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Fort Pierce, FL (US) (2000)
  • Ontario, CA (2002)
  • Ft. Pierce, FL (US) (2002)
  • Toronto, CA (2003 - 2004)

Company Filing History:


Years Active: 2000-2004

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Richard A. Isbrucker

Introduction

Richard A. Isbrucker is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that have therapeutic applications. With a total of six patents to his name, Isbrucker's work focuses on addressing critical health challenges.

Latest Patents

One of Isbrucker's latest patents involves the compositions and uses of dictyostatin compounds. Dictyostatin-1 has been found to stabilize microtubules and prohibit their depolymerization to free tubulin. Because of these activities, the dictyostatin compounds can be used in the treatment of a number of diseases in which aberrant cellular proliferation occurs, such as drug-sensitive and drug-resistant cancers, autoimmune disorders, and inflammatory diseases.

Career Highlights

Richard A. Isbrucker is affiliated with the Harbor Branch Oceanographic Institution, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

Isbrucker has collaborated with esteemed colleagues, including Ross E. Longley and Shirley A. Pomponi. These partnerships have contributed to the depth and breadth of his research endeavors.

Conclusion

Richard A. Isbrucker's innovative work in the field of biotechnology exemplifies the importance of research in developing new treatments for complex diseases. His contributions continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…